Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of SB5 High vs Low Concentration in Healthy Males
NCT04514796Phase 1Completed
- Sponsor
- Samsung Bioepis
- Start
- Aug 2020
- Primary completion
- May 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of adalimumab in rheumatoid arthritis (RA) (2 arms), sponsored by Samsung Bioepis. Primary endpoints: Area Under the Concentration-time Curve From Zero to Infinity and Maximum Serum Concentration. Started Aug 2020; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04514796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04514796.